Placebo C

DRUG2 trials

Sponsors

Novo Nordisk A/S, Sanjay Gandhi Postgraduate Institute of Medical Sciences

Conditions

Crohn's DiseaseNon-alcoholic steatohepatitis (NASH)

Phase 2

Safety and Efficacy of Artesunate & Curcumin in Crohn's Disease

Sanjay Gandhi Postgraduate Institute of Medical SciencesCrohn's Disease

Start: 2021-01-21End: 2024-01-31Target: 40Updated: 2023-05-23

Efficacy and safety investigation of NNC0194-0499 co-administered with semaglutide in subjects with non-alcoholic steatohepatitis: a dose-ranging, placebo-controlled trial.

CompletedCTIS2023-506961-74-00

Novo Nordisk A/SNon-alcoholic steatohepatitis (NASH)

Start: 2021-08-31End: 2025-03-07Target: 165Updated: 2025-01-22